Cargando…
Positron emission tomography imaging with (89)Zr-labeled anti-CD8 cys-diabody reveals CD8(+) cell infiltration during oncolytic virus therapy in a glioma murine model
Determination of treatment response to immunotherapy in glioblastoma multiforme (GBM) is a process which can take months. Detection of CD8(+) T cell recruitment to the tumor with a noninvasive imaging modality such as positron emission tomography (PET) may allow for tumor characterization and early...
Autores principales: | Kasten, Benjamin B., Houson, Hailey A., Coleman, Jennifer M., Leavenworth, Jianmei W., Markert, James M., Wu, Anna M., Salazar, Felix, Tavaré, Richard, Massicano, Adriana V. F., Gillespie, G. Yancey, Lapi, Suzanne E., Warram, Jason M., Sorace, Anna G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319402/ https://www.ncbi.nlm.nih.gov/pubmed/34321569 http://dx.doi.org/10.1038/s41598-021-94887-x |
Ejemplares similares
-
Author Correction: Positron emission tomography imaging with (89)Zr-labeled anti-CD8 cys-diabody reveals CD8(+) cell infiltration during oncolytic virus therapy in a glioma murine model
por: Kasten, Benjamin B., et al.
Publicado: (2021) -
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology
por: Kasten, Benjamin B., et al.
Publicado: (2019) -
(89)Zr-panitumumab PET imaging for preoperative assessment of ameloblastoma in a PDX model
por: Stone, Logan D., et al.
Publicado: (2022) -
[(89)Zr]-Atezolizumab-PET Imaging Reveals Longitudinal Alterations in PDL1 during Therapy in TNBC Preclinical Models
por: Massicano, Adriana V. F., et al.
Publicado: (2023) -
[(89)Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models
por: Lu, Yun, et al.
Publicado: (2021)